CAMBRIDGE, Mass., March 16, 2018 – Gamida Cell, a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming investor conferences:
A webcast of each presentation can be accessed through the links above, or from the News section of the Gamida Cell website.
About Gamida Cell
Gamida Cell is a leader in cellular and immune therapeutics dedicated to treating patients with cancer and rare genetic diseases. The company is building a diverse pipeline based on its proprietary NAM technology platform to deliver transformative medicines to patients in need of new treatment options. To learn more about Gamida Cell, including current clinical studies, please visit gamida-cell.com and on Twitter, LinkedIn and Facebook.
# # #